tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Income Statement

Compare
573 Followers

Verve Therapeutics Income Statement

Last quarter (Q3 2024), Verve Therapeutics's total revenue was $6.87M, an increase of 120.24% from the same quarter last year. In Q3, Verve Therapeutics's net income was $-50.13M. See Verve Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 11.76M$ 1.94M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 6.30M$ -4.77M$ -3.38M$ -1.33M$ -106.00K
Operating Expenses
$ 234.88M$ 167.63M$ 87.07M$ 40.63M$ 13.64M
Depreciation and Amortization
$ 5.46M$ 6.71M$ 3.38M$ 1.33M$ 106.00K
EBITDA
$ -217.67M$ -162.88M$ -85.53M$ -39.30M$ -13.54M
Operating Income
$ -223.12M$ -165.69M$ -87.07M$ -40.63M$ -13.64M
Other Income/Expenses
$ 23.33M$ 8.35M$ -33.25M$ -5.08M$ -5.66M
Pretax Income
$ -199.79M$ -157.33M$ -120.31M$ -45.70M$ -19.30M
Net Income
$ -200.07M$ -157.39M$ -118.64M$ -45.54M$ -19.02M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.12$ -2.91$ -2.45$ -0.94$ -0.39
Diluted EPS
$ -3.12$ -2.91$ -2.45$ -0.94$ -0.39
Weighted Average Shares Outstanding
64.18M 54.02M 48.51M 48.22M 48.22M
Weighted Average Shares Outstanding (Diluted)
64.18M 54.02M 48.51M 48.22M 48.22M
Currency in USD

Verve Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis